Alcon (ALC) Competitors

$63.66 -0.34 (-0.53%)

Closing price 05/15/2026 03:59 PM Eastern

Extended Trading

$63.59 -0.07 (-0.11%)

As of 05/15/2026 06:29 PM Eastern

ALC vs. COO, DXCM, HCA, THC, and EHC

Should you buy Alcon stock or one of its competitors? MarketBeat compares Alcon with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Alcon include Cooper Companies (COO), DexCom (DXCM), HCA Healthcare (HCA), Tenet Healthcare (THC), and Encompass Health (EHC). These companies are all part of the "medical" sector.

How does Alcon compare to Cooper Companies?

Alcon (NYSE:ALC) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Cooper Companies has a net margin of 9.67% compared to Alcon's net margin of 7.70%. Cooper Companies' return on equity of 10.34% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
Cooper Companies	9.67%	10.34%	6.93%

53.9% of Alcon shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 1.5% of Alcon shares are held by insiders. Comparatively, 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Alcon has higher revenue and earnings than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.03	$980M	$1.66	38.35
Cooper Companies	$4.09B	2.84	$374.90M	$2.02	29.51

Alcon has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.89, meaning that its stock price is 11% less volatile than the broader market.

In the previous week, Cooper Companies had 8 more articles in the media than Alcon. MarketBeat recorded 13 mentions for Cooper Companies and 5 mentions for Alcon. Cooper Companies' average media sentiment score of 0.56 beat Alcon's score of 0.44 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cooper Companies	4 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	4 Negative mention(s)	1 Very Negative mention(s)	Positive

Alcon presently has a consensus target price of $85.12, indicating a potential upside of 33.71%. Cooper Companies has a consensus target price of $90.79, indicating a potential upside of 52.30%. Given Cooper Companies' higher probable upside, analysts plainly believe Cooper Companies is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.70
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53

Summary

Alcon beats Cooper Companies on 9 of the 17 factors compared between the two stocks.

How does Alcon compare to DexCom?

Alcon (NYSE:ALC) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

DexCom has a net margin of 19.31% compared to Alcon's net margin of 7.70%. DexCom's return on equity of 33.33% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
DexCom	19.31%	33.33%	13.19%

53.9% of Alcon shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 1.5% of Alcon shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Alcon has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.03	$980M	$1.66	38.35
DexCom	$4.66B	5.10	$836.30M	$2.34	26.34

Alcon has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, DexCom has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

In the previous week, DexCom had 28 more articles in the media than Alcon. MarketBeat recorded 33 mentions for DexCom and 5 mentions for Alcon. DexCom's average media sentiment score of 0.77 beat Alcon's score of 0.44 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DexCom	20 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Alcon currently has a consensus target price of $85.12, indicating a potential upside of 33.71%. DexCom has a consensus target price of $83.22, indicating a potential upside of 35.03%. Given DexCom's stronger consensus rating and higher possible upside, analysts plainly believe DexCom is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.70
DexCom	1 Sell rating(s)	3 Hold rating(s)	18 Buy rating(s)	3 Strong Buy rating(s)	2.92

Summary

DexCom beats Alcon on 13 of the 17 factors compared between the two stocks.

How does Alcon compare to HCA Healthcare?

Alcon (NYSE:ALC) and HCA Healthcare (NYSE:HCA) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

HCA Healthcare has higher revenue and earnings than Alcon. HCA Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.03	$980M	$1.66	38.35
HCA Healthcare	$75.60B	1.24	$6.78B	$29.08	14.54

53.9% of Alcon shares are owned by institutional investors. Comparatively, 62.7% of HCA Healthcare shares are owned by institutional investors. 1.5% of Alcon shares are owned by insiders. Comparatively, 1.5% of HCA Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, HCA Healthcare had 8 more articles in the media than Alcon. MarketBeat recorded 13 mentions for HCA Healthcare and 5 mentions for Alcon. HCA Healthcare's average media sentiment score of 1.37 beat Alcon's score of 0.44 indicating that HCA Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
HCA Healthcare	13 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Alcon currently has a consensus target price of $85.12, indicating a potential upside of 33.71%. HCA Healthcare has a consensus target price of $517.82, indicating a potential upside of 22.51%. Given Alcon's stronger consensus rating and higher possible upside, analysts plainly believe Alcon is more favorable than HCA Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.70
HCA Healthcare	1 Sell rating(s)	7 Hold rating(s)	16 Buy rating(s)	0 Strong Buy rating(s)	2.63

Alcon has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, HCA Healthcare has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market.

HCA Healthcare has a net margin of 8.89% compared to Alcon's net margin of 7.70%. Alcon's return on equity of 7.11% beat HCA Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
HCA Healthcare	8.89%	-295.93%	11.21%

Summary

HCA Healthcare beats Alcon on 10 of the 17 factors compared between the two stocks.

How does Alcon compare to Tenet Healthcare?

Tenet Healthcare (NYSE:THC) and Alcon (NYSE:ALC) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

Tenet Healthcare has higher revenue and earnings than Alcon. Tenet Healthcare is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenet Healthcare	$21.31B	0.79	$1.41B	$19.23	10.21
Alcon	$10.40B	3.03	$980M	$1.66	38.35

95.4% of Tenet Healthcare shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 0.8% of Tenet Healthcare shares are held by company insiders. Comparatively, 1.5% of Alcon shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Tenet Healthcare had 4 more articles in the media than Alcon. MarketBeat recorded 9 mentions for Tenet Healthcare and 5 mentions for Alcon. Tenet Healthcare's average media sentiment score of 0.74 beat Alcon's score of 0.44 indicating that Tenet Healthcare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tenet Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Alcon	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tenet Healthcare currently has a consensus target price of $244.16, suggesting a potential upside of 24.32%. Alcon has a consensus target price of $85.12, suggesting a potential upside of 33.71%. Given Alcon's higher probable upside, analysts plainly believe Alcon is more favorable than Tenet Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenet Healthcare	0 Sell rating(s)	3 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.70

Tenet Healthcare has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, Alcon has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market.

Tenet Healthcare has a net margin of 7.94% compared to Alcon's net margin of 7.70%. Tenet Healthcare's return on equity of 25.55% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenet Healthcare	7.94%	25.55%	5.15%
Alcon	7.70%	7.11%	4.98%

Summary

Tenet Healthcare beats Alcon on 12 of the 17 factors compared between the two stocks.

How does Alcon compare to Encompass Health?

Alcon (NYSE:ALC) and Encompass Health (NYSE:EHC) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Alcon presently has a consensus target price of $85.12, suggesting a potential upside of 33.71%. Encompass Health has a consensus target price of $144.17, suggesting a potential upside of 35.19%. Given Encompass Health's stronger consensus rating and higher probable upside, analysts plainly believe Encompass Health is more favorable than Alcon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.70
Encompass Health	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.11

Encompass Health has a net margin of 10.04% compared to Alcon's net margin of 7.70%. Encompass Health's return on equity of 18.28% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	7.70%	7.11%	4.98%
Encompass Health	10.04%	18.28%	8.27%

Alcon has higher revenue and earnings than Encompass Health. Encompass Health is trading at a lower price-to-earnings ratio than Alcon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.03	$980M	$1.66	38.35
Encompass Health	$5.94B	1.78	$566.20M	$5.99	17.80

In the previous week, Encompass Health had 19 more articles in the media than Alcon. MarketBeat recorded 24 mentions for Encompass Health and 5 mentions for Alcon. Alcon's average media sentiment score of 0.44 beat Encompass Health's score of 0.18 indicating that Alcon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Encompass Health	5 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alcon has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market. Comparatively, Encompass Health has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

53.9% of Alcon shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 1.5% of Alcon shares are held by insiders. Comparatively, 1.8% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Encompass Health beats Alcon on 9 of the 16 factors compared between the two stocks.

Get Alcon News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALC vs. The Competition

Export

Metric	Alcon	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$31.48B	$6.69B	$6.37B	$22.74B
Dividend Yield	N/A	1.76%	2.80%	4.12%
P/E Ratio	38.35	49.11	20.66	29.73
Price / Sales	3.03	40.69	549.65	23.27
Price / Cash	11.61	23.95	42.43	24.79
Price / Book	1.42	6.49	9.87	4.60
Net Income	$980M	$158.34M	$3.57B	$1.06B
7 Day Performance	1.85%	-2.95%	0.23%	-2.27%
1 Month Performance	-21.75%	-6.28%	-2.54%	-1.66%
1 Year Performance	-29.10%	-4.45%	33.54%	21.94%

Alcon Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALC Alcon	3.9164 of 5 stars	$63.66 -0.5%	$85.12 +33.7%	-29.1%	$31.48B	$10.40B	38.35	25,942	Analyst Forecast
COO Cooper Companies	3.9845 of 5 stars	$61.52 -1.3%	$90.79 +47.6%	-28.1%	$12.17B	$4.09B	30.46	15,000
DXCM DexCom	4.6712 of 5 stars	$60.04 -2.1%	$83.50 +39.1%	-27.9%	$23.67B	$4.66B	25.66	11,000	Trending News
HCA HCA Healthcare	4.8021 of 5 stars	$427.71 -1.2%	$517.82 +21.1%	+9.1%	$96.08B	$75.60B	14.71	320,000	Positive News
THC Tenet Healthcare	4.5814 of 5 stars	$185.24 +1.1%	$242.89 +31.1%	+18.6%	$16.06B	$21.31B	9.63	99,000	Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ALC) was last updated on 5/17/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alcon (ALC) Competitors

ALC vs. COO, DXCM, HCA, THC, and EHC

How does Alcon compare to Cooper Companies?

Summary

How does Alcon compare to DexCom?

Summary

How does Alcon compare to HCA Healthcare?

Summary

How does Alcon compare to Tenet Healthcare?

Summary

How does Alcon compare to Encompass Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALC vs. The Competition

Alcon Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alcon (ALC) Competitors

ALC vs. COO, DXCM, HCA, THC, and EHC

How does Alcon compare to Cooper Companies?

Is ALC or COO more profitable?

Do institutionals & insiders have more ownership in ALC or COO?

Which has higher valuation & earnings, ALC or COO?

Which has more risk & volatility, ALC or COO?

Does the media refer more to ALC or COO?

Do analysts recommend ALC or COO?

Summary

How does Alcon compare to DexCom?

Is ALC or DXCM more profitable?

Do insiders and institutionals have more ownership in ALC or DXCM?

Which has stronger valuation and earnings, ALC or DXCM?

Which has more volatility and risk, ALC or DXCM?

Does the media refer more to ALC or DXCM?

Do analysts prefer ALC or DXCM?

Summary

How does Alcon compare to HCA Healthcare?

Which has stronger valuation and earnings, ALC or HCA?

Do insiders and institutionals have more ownership in ALC or HCA?

Does the media refer more to ALC or HCA?

Do analysts prefer ALC or HCA?

Which has more volatility and risk, ALC or HCA?

Is ALC or HCA more profitable?

Summary

How does Alcon compare to Tenet Healthcare?

Which has stronger earnings & valuation, THC or ALC?

Do institutionals and insiders have more ownership in THC or ALC?

Does the media prefer THC or ALC?

Do analysts rate THC or ALC?

Which has more risk & volatility, THC or ALC?

Is THC or ALC more profitable?

Summary

How does Alcon compare to Encompass Health?

Do analysts recommend ALC or EHC?

Is ALC or EHC more profitable?

Which has higher earnings and valuation, ALC or EHC?

Does the media favor ALC or EHC?

Which has more risk and volatility, ALC or EHC?

Do insiders & institutionals have more ownership in ALC or EHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALC vs. The Competition

Alcon Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools